STRATA Skin Sciences, Inc. (SSKN) Revenue History
Annual and quarterly revenue from 2003 to present
SSKN Revenue Over Time (2003–2025)
SSKN Revenue Growth History
8 of 13 years with positive growth- FY2003 revenue growth
- N/A
- FY2004 revenue growth
- N/A
- FY2005 revenue growth
- N/A
- FY2006 revenue growth
- N/A
- FY2007 revenue growth
- N/A
- FY2008 revenue growth
- N/A
- FY2009 revenue growth
- N/A
- FY2010 revenue growth
- N/A
- FY2011 revenue growth
- N/A
- FY2012 revenue growth
- N/A
- FY2013 revenue growth
- +92.5%
- FY2014 revenue growth
- +70.7%
- FY2015 revenue growth
- +1921.3%
- FY2016 revenue growth
- +71.7%
- FY2017 revenue growth
- -1.0%
- FY2018 revenue growth
- -5.1%
- FY2019 revenue growth
- +5.8%
- FY2020 revenue growth
- -26.9%
- FY2021 revenue growth
- +29.8%
- FY2022 revenue growth
- +20.6%
- FY2023 revenue growth
- -7.8%
- FY2024 revenue growth
- +0.6%
- FY2025 revenue growth
- -8.5%
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $9.3M | -3.0% |
| Q3 2025 | $6.9M | -21.2% |
| Q2 2025 | $7.7M | -9.2% |
| Q1 2025 | $6.8M | +0.9% |
| Q4 2024 | $9.6M | +10.2% |
| Q3 2024 | $8.8M | -0.6% |
| Q2 2024 | $8.4M | +2.2% |
| Q1 2024 | $6.8M | -10.7% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2024)
SSKN's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
SSKN Revenue Analysis (2003–2025)
Current Revenue & Growth
As of June 21, 2026, STRATA Skin Sciences, Inc. (SSKN) generated trailing twelve-month (TTM) revenue of $30.7 million, reflecting slight decline in growth of -3.0% year-over-year. The most recent quarter (Q4 2025) recorded $9.3 million in revenue, up 34.1% sequentially.
Historical Growth Trajectory
SSKN's 5-year compound annual growth rate (CAGR) stands at +5.9%, indicating steady revenue expansion. The 3-year CAGR of -5.3% is below the 5-year average, signalling a growth deceleration in recent years. STRATA Skin Sciences, Inc.'s highest annual revenue of $36.2 million was recorded in 2022.
Revenue by Segment
SSKN's revenue is primarily driven by Dermatology Recurring Procedures (63%), and Dermatology Procedures Equipment (37%). With over half of revenue concentrated in Dermatology Recurring Procedures, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including DERM (+15.0% YoY), SKIN (-8.2% YoY), and LNTH (+0.6% YoY) — SSKN has underperformed the peer group in revenue growth. Compare SSKN vs DERM →
SSKN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SSKNCurrent | $31M | -3.0% | +5.9% | -19.0% | |
 DERM | $62M | +15.0% | +6.8% | -13.2% | |
 SKIN | $301M | -8.2% | +20.4% | -6.9% | |
 LNTH | $1.5B | +0.6% | +35.3% | 20.2% | |
 INMD | $370M | -4.5% | +12.4% | 23.0% | |
 AEYE | $40M | +11.6% | +14.5% | -7.9% |
SSKN Historical Revenue Data (2003–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $30.7M | -8.5% | $17.9M | 58.3% | $-5,835,000 | -19.0% |
| 2024 | $33.6M | +0.6% | $19.1M | 56.9% | $-9,255,000 | -27.6% |
| 2023 | $33.4M | -7.8% | $18.5M | 55.3% | $-8,604,000 | -25.8% |
| 2022 | $36.2M | +20.6% | $21.8M | 60.2% | $-4,649,000 | -12.9% |
| 2021 | $30.0M | +29.8% | $19.9M | 66.2% | $-4,402,000 | -14.7% |
| 2020 | $23.1M | -26.9% | $14.1M | 61.2% | $-4,076,000 | -17.7% |
| 2019 | $31.6M | +5.8% | $20.3M | 64.2% | $-3,010,000 | -9.5% |
| 2018 | $29.9M | -5.1% | $17.1M | 57.3% | $-3,355,000 | -11.2% |
| 2017 | $31.4M | -1.0% | $18.0M | 57.1% | $-2,410,000 | -7.7% |
| 2016 | $31.8M | +71.7% | $19.1M | 60.2% | $-3,597,000 | -11.3% |
| 2015 | $18.5M | +1921.3% | $4.8M | 25.8% | $-16,475,000 | -89.1% |
| 2014 | $915K | +70.7% | $-4,020,000 | -439.3% | $-16,622,000 | -1816.6% |
| 2013 | $536K | +92.5% | $-3,805,000 | -709.9% | $-24,134,000 | -4502.6% |
| 2012 | $278K | - | $-1,763,872 | -633.4% | $-22,724,566 | -8160.8% |
| 2011 | $0 | - | $0 | - | $-20,462,231 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
23+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SSKN — Frequently Asked Questions
Quick answers to the most common questions about buying SSKN stock.
Is SSKN's revenue growth accelerating or slowing?
SSKN revenue growth is slowing. TTM revenue is $31M, up -3.0% year-over-year — below the 5-year CAGR of +5.9%. The deceleration suggests maturing end-markets or increased competition.
What is SSKN's revenue history from 2003 to 2026?
STRATA Skin Sciences, Inc. (SSKN) revenue history spans 2003 to 2026. TTM revenue as of 2026 is $31M, growing at -3.0% YoY. The 5-year CAGR is +5.9%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is SSKN's long-term revenue growth rate (CAGR)?
STRATA Skin Sciences, Inc.'s 5-year revenue CAGR of +5.9% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -3.0% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for SSKN.
Why does SSKN's quarterly revenue fluctuate?
SSKN quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. STRATA Skin Sciences, Inc.'s revenue data from 2003 to 2026 shows full historical quarterly detail on this page.
How is SSKN's revenue distributed by segment?
SSKN reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does SSKN's revenue compare to industry peers?
STRATA Skin Sciences, Inc. (SSKN) with TTM revenue of $31M and -3.0% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.